Fred Meyer Stores debuts $4 generic Rx

13 April 2008

Starting April 4, Fred Meyer Stores and QFC began offering US pharmacy customers some generic drugs for $4 per prescription. The $4 generic prescriptions will be available at all QFC pharmacies in the sttes of Washington and Oregon, and at all Fred Meyer pharmacies in Idaho, Oregon and Washington. The $4 price will apply to more than 300 generic drugs prescribed for 30-day supplies for commonly prescribed dosages.

The Fred Meyer and QFC programs include generic alternatives for some of the most commonly-prescribed drugs used to treat conditions such as diabetes, asthma, depression, heart disease, thyroid and other health problems.The $4 generic prescriptions provide Fred Meyer and QFC customers with an affordable alternative to meet their health care and medication needs. Customers interested in the low-price generic drugs should consult their doctors or pharmacists to determine if a generic drug is available for their prescription and if it is right for them.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight